Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T07:03:26.079Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunology and psychosis: 22q11.2 syndrome as a model of study

Published online by Cambridge University Press:  01 September 2022

C. Garcia-Bernal  and
M.R. El-Idrissi Benhnia
C. Garcia-Bernal*
Affiliation:
University Hospital Virgen del Rocio, Psychiatry, Seville, Spain
M.R. El-Idrissi Benhnia
Affiliation:
Investigation Institute of Biomedicine of Seville, Biochemistry, Molecular Biology And Immunology, Seville, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The 22q11.2 deletion syndrome (22q11DS) defines a set of developmental abnormalities due to a loss of genetic material. Phenotypic expression is highly varied. The immunological alterations that present as a severe combined immunodeficiency and the neurodevelopmental alterations stand out, especially the psychotic symptoms. It is the best described genetic alteration for the development of psychosis, presenting up to 30% of patients with compatible symptoms, with various hypotheses that justify it.

Objectives

General objective:

1. Justify that SD2q11 can be used as a model for human research on the origin of psychosis.

Specific objectives

1. Describe the pro-inflammatory state present in SD2q11.

2. Describe differences at the immunological level in SD2q11 among those patients with presence of psychotic symptoms of those who do not present them.

3. Describe possible biomarkers.

Methods

A systematic review of the literature in the last 5 years using electronic resources (PubMed and WOS) until June 2021 following the PRISMA recommendations.

Results

Three original articles were reviewed. There is a very marked pro-inflammatory state in 22q11DS patients with psychotic symptoms. They present an increase in subpopulations of CD4. The IL-17 is important in the formation in primitive stages of the hippocampus, its ease of breaking the blood-brain barrier (BBB). The neutrophil / lymphocyte ratio is presented as a possible biomarker to predict patients at high risk of developing psychosis.

Conclusions

There is sufficient evidence that patients with 22q11DS can be used as a research model regarding possible hypotheses about the genesis of psychosis.

Disclosure

No significant relationships.

Keywords

Digeorge syndromepsychosisschizophreniainflammation
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S700
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.